FdaApplication

ANDA 204644

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMYLAN PHARMACEUTICALS INC
application_typeANDA
approval_date2017-06-21

Products (2)

ProductActive ingredientStrengthDosage form
IMATINIB MESYLATEIMATINIB MESYLATEEQ 400MG BASETABLET;ORAL
IMATINIB MESYLATEIMATINIB MESYLATEEQ 100MG BASETABLET;ORAL

2 products